编者按:2019年即将步入尾声,回望过去的一年,无论是在鼻咽癌的基础研究亦或是临床实践领域,许多研究者、临床工作者都为了该学科的进步付出了很多努力,其中不乏一些振奋人心的成果…… 追本溯源,基础研究对预防工作开展有指导意义 临床研究助力早诊早治,预后风险评估研究指导临床决策 推陈出新,中晚期鼻咽癌综合治疗新方案有望被国际指南采纳 总结 参考文献 1. Xu M, Yao Y, Chen H et al. Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. Nature genetics 2019; 1. 2. Li Z, Tsai M-H, Shumilov A et al. Epstein–Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus production. Nature microbiology 2019; 4: 2475-2486. 3. Ji M, Sheng W, Cheng W et al. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China. Annals of Oncology 2019; 30: 1630-1637. 4. King A, Woo J, Ai Q et al. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma. Annals of Oncology 2019; 30: 977-982. 5. Lv J, Chen Y, Zhou G et al. Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma. Nature communications 2019; 10: 1-10. 6. Zhang Y, Chen L, Hu G-Q et al. Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. The New England journal of medicine 2019; 381: 1124. 7. Rodriguez-Galindo C, Krailo MD, Krasin MJ et al. Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children’s Oncology Group ARAR0331 Study. Journal of Clinical Oncology 2019; JCO. 19.01276 麦海强教授 麦海强,中山大学肿瘤防治中心教授、主任医师、博士生导师、鼻咽科副主任,2014国家杰出青年基金获得者。目前担任美国MD Anderson 癌症中心质子治疗中心学术委员会委员,中国抗癌协会青年理事会理事,中国抗癌协会鼻咽癌专业委员会委员,广东省医学会肿瘤学分会鼻咽癌学组副组长,广东省临床医学学会-华南名医专家委员会委员,《Chinese Journal of Cancer》、《国际肿瘤学杂志》和《实用肿瘤学杂志》编委。 (来源:《肿瘤瞭望》编辑部) |
|